As with all Biotechs, the timeframe required to achieve success...

As with all Biotechs, the timeframe required to achieve success is much longer than most other industry sectors.

And the risks are usually quite high.

With Phylogica the chances of success are quite strong, which is evident from the number of quality collaborations they have with top-tier international biotechs, pharmaceuticals and research organisations.

This company is not 'mucking around' as some other biotechs do. It's not an easy sector to pick the winners from the losers.

PYC's phylomer technology has proven to have a great deal of merit that has been very well patented.

The company has an outstanding management team with a great deal of experience backed up by sophisticated investors.

This share is definitely worth holding if you have some and buying more if you have cash imo.
As many have been saying on this thread, the reward potential is very high.

Do your own research to verify my thoughts -there's plenty of information out there about this company and the space they are in.

Cheers to all holders!